Previous 10 | Next 10 |
2023-05-17 10:16:29 ET Pharmaceutical company Achieve Life Sciences ( NASDAQ: ACHV ) said on Wednesday that it has refinanced an outstanding loan. The loan is a the part of a previous debt agreement with Silicon Valley Bank, a division of First-Citizens Bank. The new ...
SEATTLE and VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced the C...
2023-05-09 22:02:06 ET Achieve Life Sciences, Inc. (ACHV) Q1 2023 Earnings Conference Call May 09, 2023, 04:30 PM ET Company Participants Nicole Jones - Investor Relations John Bencich - Chief Executive Officer Cindy Jacobs - President and Chief Medical Officer ...
2023-05-09 17:02:03 ET Achieve Life Sciences press release ( NASDAQ: ACHV ): Q1 GAAP EPS of -$0.50 beats by $0.19 . As of March 31, 2023, the Company’s cash, cash equivalents, and restricted cash was $16.6 million. Shares +1.02% AH. For further det...
SEATTLE and VANCOUVER, British Columbia, May 09, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced first...
2023-05-08 17:35:58 ET Achieve Life Sciences ( NASDAQ: ACHV ) is scheduled to announce Q1 earnings results on Tuesday, May 9th, after market close. The consensus EPS Estimate is -$0.69 Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downwar...
2023-05-08 17:35:56 ET Major earnings expected after the bell on Tuesday include: Airbnb ( ABNB ) Occidental Petroleum Corporation ( OXY ) Twilio ( TWLO ) Virgin Galactic Holdings ( SPCE ) Upstart Holdings ( UPST ) For further details see: ...
Shares of Achieve Life Sciences, Inc. (NASDAQ: ACHV) traded at a new 52-week high today and are currently trading at $8.42. So far today, approximately 47,759 shares have been exchanged, as compared to an average 30-day volume of 187.2k shares. Achieve Life Sciences, Inc., a clinical-stage ph...
SEATTLE and VANCOUVER, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today anno...
2023-04-25 16:37:49 ET Summary Positive Phase 2 ORCA-V1 trial results show cytisinicline's potential in helping users quit vaping, with an odds ratio of 2.6 compared to placebo, suggesting a strong case for FDA approval. Cytisinicline demonstrated a favorable safety profile with n...
News, Short Squeeze, Breakout and More Instantly...
Achieve Life Sciences Inc. Company Name:
ACHV Stock Symbol:
NASDAQ Market:
Achieve Life Sciences Inc. Website:
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that...
SEATTLE and VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, announced that the c...